The mean percentage of body weight loss at 72 weeks was 15.0% at the lowest dose, and 20.9% in the highest dose cohort (compared to 3.1% in placebo) (NCT04184622)
As glucose control is the foundation of diabetes management, most international guidelines recommend the use of metformin together with lifestyle changes as the first line of management in newly diagnosed type 2 diabetes (T2D) patients [9,10,11]
Since the cuprizone regimen was several times higher than those regularly used in cuprizone studies, we used simple tests to determine animal responsiveness and impairment
AST and ALT primarily identify hepatocyte injury rather than the efficiency of every methylation, conjugation or transport pathway
Reshmi Srinath, director of the Weight and Metabolism Management Program at NYU Langone Health, emphasizes that there is no rigorous scientific evidence supporting microdosing approaches